CAN-FITE BIOPHARMA LTD's ticker is CANF and the CUSIP is 13471N102. A total of 13 filers reported holding CAN-FITE BIOPHARMA LTD in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $3,000 | -25.0% | 3,400 | 0.0% | 0.00% | -100.0% |
| Q4 2018 | $4,000 | 0.0% | 3,400 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $4,000 | 0.0% | 3,400 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $4,000 | -20.0% | 3,400 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $5,000 | 0.0% | 3,400 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $5,000 | – | 3,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TAYLOR ASSET MANAGEMENT INC | 348,500 | $763,000 | 0.14% |
| MENTA CAPITAL LLC | 12,200 | $27,000 | 0.00% |
| Virtu KCG Holdings LLC | 22,042 | $48,000 | 0.00% |
| MSI Financial Services Inc | 2,000 | $4,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 458 | $1,000 | 0.00% |
| UBS Group AG | 5,194 | $11,000 | 0.00% |
| CITIGROUP INC | 17 | $0 | 0.00% |